GlassScriptPhysician profile
Denise Dietz
NPI 1821290214
$4,895.00
in general payments reported to CMS, 2019-2025
41 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,555 · 2020: $1,137 · 2021: $36.42 · 2022: $534 · 2023: $745 · 2024: $574 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,632.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $681.41 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $520.32 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $388.57 | 2019-2022 | |
| Abbott Laboratories | $300.27 | 2020-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Janssen Pharmaceuticals, INC | $286.06 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.57 | 2019-2023 | |
| Pfizer INC. | $262.03 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $167.59 | 2022-2025 | Assure Wcd |
| Amarin Pharma, INC. | $160.01 | 2019-2020 | |
| Akcea Therapeutics, INC. | $153.71 | 2019-2020 | |
| Irhythm Technologies, INC. | $145.37 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $141.25 | 2023 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $135.22 | 2019-2024 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $128.31 | 2019-2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $109.48 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $100.99 | 2024 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $100.16 | 2019-2022 | |
| Medtronic Vascular, INC. | $98.59 | 2019 | |
| Alnylam Pharmaceuticals INC. | $97.34 | 2022-2025 | Onpattro |
| Philips North America LLC | $79.98 | 2025 | Extended Holter, Ambulatory Monitoring & Diagnostics Undivided |
| Bayer Healthcare Pharmaceuticals INC. | $76.36 | 2019-2022 | |
| Atricure, INC. | $70.83 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Impulse Dynamics (USA) INC. | $63.99 | 2024 | Optimizer |
| Gilead Sciences, INC. | $42.26 | 2019 | |
| Bardy Diagnostics, INC. | $33.60 | 2020-2022 | |
| Heartflow, INC. | $26.01 | 2025 | |
| Boston Scientific Corporation | $24.26 | 2023 | Watchman Access System |
| Novo Nordisk INC | $23.20 | 2024 | Rybelsus, Ozempic |
| Smith+Nephew, INC. | $19.50 | 2023 | Pico, Renasys Go V2 Home |
| Medicomp INC | $19.24 | 2024 | Telepatch Cardiac Monitor |
| Vifor Pharma, INC. | $18.73 | 2019 | |
| Welch Allyn | $18.00 | 2019 | |
| Lundbeck LLC | $17.98 | 2020 | |
| Nuwellis, INC. | $17.42 | 2019 | |
| Baxter Healthcare | $17.30 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Lantheus Medical Imaging, INC. | $16.44 | 2023 | Definity |
| Vital Connect, INC | $16.06 | 2023 | Vitalpatch Rtm |
| Chiesi USA, INC. | $15.78 | 2020 | |
| Esperion Therapeutics, INC. | $12.62 | 2022 | |
| Merck Sharp & Dohme LLC | $12.12 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Dietz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.